chugai pharmaceutical co ltd
(4519:Tokyo Stock Exchange)
Executive Profile*
Osamu NagayamaChairman of The Board and Chief Executive Officer, Chugai Pharmaceutical Co. Ltd. |
| Age | Total Calculated Compensation | This person is connected to 45 board members in 4 different organizations across 5 different industries. See Board Relationships |
| 65 | -- |
Background*
Mr. Osamu Nagayama serves as the Chief Executive Officer of Chugai Pharmaceutical Co. Ltd. Mr. Nagayama served as President and Chief Operating Officer of Chugai Pharmaceutical Co. Ltd. until February 2012. He has been with Chugai Pharmaceutical Co. Ltd. since 1978. He served as a Director of Pharmaceutical Sales & Marketing Division and International Business Division of Chugai since 1983, Deputy General Manager of Pharmaceutical Research and Development Division. Since ...
Corporate Headquarters*1-1 Nihonbashi-muromachi 2-chomeTokyo, -- 103-8324 Japan Phone: 81 3 3281 6611 Fax: 81 3 3281 2828 Board Members Memberships*Chairman of The Board and Chief Executive Officer 2005-Present Independent Director 2010-Present Vice Chairman and Member of Nominating Committee
Education*There is no Education data available.Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*There is no Total Compensation data available. |
| Recently Viewed | |||
| 4519:JP | ¥2,433.00 JPY | +5.00 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Robert A. Bradway | Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee Amgen Inc. | $1.3M |
| Robert J. Hugin MBA | Chairman, Chief Executive Officer, President and Chairman of Executive Committee Celgene Corporation | $1.2M |
| Haruo Naito | Chief Executive Officer, President and Director Eisai Co., Ltd. | -- |
| F. Michael Ball | Chief Executive Officer, Director and Member of Science, Technology & Quality Committee Hospira Inc. | $993.3K |
| Daniel J. Abdun-Nabi | Chief Executive Officer, President, Director and Member of Strategic Operations Committee Emergent BioSolutions, Inc. | $860.3K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Northglenn, CO | Office DepotPosted: Mar 01
Sponsored Financial Commentaries
Sponsored Links
To contact CHUGAI PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
